Your Article Summary
See Latest ArticlesCell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding
Cell Therapeutics, 06/22/09
Cell Therapeutics, Inc. announced the final results of its separate concurrent fixed price exchange offers for any and all of the approximately $118.9 million outstanding principal amount of five series of its convertible notes. The Exchange Offers expired, New York City time, on Tuesday, June 2009.
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
VA Re-Ups with QuadraMed
HealthDataManagement, 12/18/09
Bristol-Myers Squibb Sets Exchange Ratio of 0.6313 for the Exchange Offer
Bristol Myers-Squibb Company, 12/17/09
Abbott Declares 344th Consecutive Quarterly Dividend
Abbott, 12/15/09